GlassScriptPhysician profile
Aditi Thakkar
NPI 1417482522
$1,186.01
in general payments reported to CMS, 2019-2025
14 companies · $366 in 2025
The $366 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $69.68 · 2022: $165 · 2023: $233 · 2024: $352 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.74 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $601.92 | 2022-2025 | Korlym |
| Mannkind Corporation | $174.61 | 2020-2025 | Afrezza |
| Medtronic, INC. | $59.09 | 2023 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Insulet Corporation | $59.03 | 2023-2024 | Omnipod |
| Recordati_rare_diseases_inc. | $58.93 | 2025 | Isturisa |
| Horizon Therapeutics Plc | $48.26 | 2022 | |
| Abbott Laboratories | $29.38 | 2025 | Freestyle Libre 3 |
| Arkray USA, INC. | $27.32 | 2023 | |
| Dexcom, INC. | $26.09 | 2024 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $24.49 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Soleno Therapeutics, INC. | $22.09 | 2025 | Vykat Xr |
| Sequel Med Tech, LLC | $21.48 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $19.52 | 2024 | Recorlev |
| Beta Bionics, INC. | $13.80 | 2023 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditi Thakkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.